Defense Threat Reduction Agency

Funds defense technologies that reduce chemical, biological, radiological, nuclear, and emerging security threats.

The Defense Threat Reduction Agency is the U.S. defense agency focused on countering weapons of mass destruction. It sits under the Department of Defense and centers its research mission on chemical, biological, radiological, nuclear, and explosives threats. The agency's RDT&E budget was about $654 million in FY2023, which gives its external research portfolio a meaningful but tightly targeted scale.

The clean public entry point is the HDTRA1 BAA series, especially the C-WMD basic research lane and the chemical and biological technologies track. That mechanism supports universities, nonprofits, and other research organizations through grants or cooperative agreements, while industry usually enters through contracts or other transaction agreements. Award ranges in the available BAA parameters run from $300,000 to $5 million, with rolling submissions.

DTRA is a fit for research teams that can tie a concrete scientific advance to a specific defense mission, especially in pathogen detection, biosecurity, nuclear sensing, or explosive defeat. The strongest proposals usually read as mission-driven research with a clear transition path, not broad platform science, and the BAA structure rewards applicants that match a specific thrust with a credible technical plan.